AstraZeneca announces new support program for patients on ARIMIDEX

NewsGuard 100/100 Score

AstraZeneca (NYSE: AZN) today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.

When using the ARIMIDEX Savings Card, patients with prescription coverage and copay of more than $50 can get up to $50 in instant savings, up to a maximum of 6 times, each time they fill an ARIMIDEX prescription.  

The process to receive an ARIMIDEX Savings Card entails no paperwork for patients. Patients can contact their health care provider and then check eligibility requirements by calling the AstraZeneca Information Center at 1-800-236-9933, Monday to Friday from 8 AM to 6 PM ET, excluding holidays. If eligible, patients can obtain an ARIMIDEX Savings Card from their health care provider or from the AstraZeneca Information Center. In addition, by the end of July, patients will be able to download the ARIMIDEX Savings Card on www.inyourcorner.com. Patients should present their ARIMIDEX Savings Card to a participating pharmacist, along with their prescription and insurance card, and they may receive instant savings, up to $50 per fill, up to six fills.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New microfluidic device improves the separation of tumor cells and clusters from malignant effusions